|
Report No. : |
330815 |
|
Report Date : |
24.07.2015 |
IDENTIFICATION DETAILS
|
Name : |
AL ESRAA PHARMACEUTICALS (OPTIMA) |
|
|
|
|
Registered Office : |
El Serag Mall, Tower 3, Entrance No. 6, 5th Floor, Cairo |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Financials (as on) : |
31.12.2014 |
|
|
|
|
Date of Incorporation : |
2011 |
|
|
|
|
Com. Reg. No.: |
15076 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Engaged in the manufacture of dental care products, skin care products
and pharmaceuticals. |
|
|
|
|
No. of Employees : |
75 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made on
e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Egypt |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EGYPT - ECONOMIC OVERVIEW
Occupying the northeast corner of the African continent,
Egypt is bisected by the highly fertile Nile valley, where most economic
activity takes place. Egypt's economy was highly centralized during the rule of
former President Gamal Abdel NASSER but opened up considerably under former
Presidents Anwar EL-SADAT and Mohamed Hosni MUBARAK. Cairo from 2004 to 2008
pursued business climate reforms to attract foreign investment and facilitate
growth. Poor living conditions and limited job opportunities for the average
Egyptian contribute to public discontent, a major factor leading to the January
2011 revolution that ousted Mubarak. The uncertain political, security, and
policy environment since 2011 caused economic growth to slow significantly,
hurting tourism, manufacturing, and other sectors and pushing up unemployment.
Weak growth and limited foreign exchange earnings have made public finances
unsustainable, leaving authorities dependent on expensive borrowing for deficit
finance and on Gulf allies to help cover the import bill. Egypt's current
Constitution passed in a referendum that took place in January 2014.
|
Source
: CIA |
Company Name :
AL ESRAA PHARMACEUTICALS (OPTIMA)
Country of Origin :
Egypt
Legal Form :
Limited Liability Company
Registration Date :
2011
Commercial Registration Number :
15076, Cairo
Tax Card Number :
212-899-066
Issued Capital :
£E 3,000,000
Paid up Capital :
£E 3,000,000
Total Workforce : 75
Activities :
Manufacturers of dental care products, skin care products and
pharmaceuticals.
Financial Condition :
Fair
Payments :
Nothing detrimental uncovered
Operating Trend :
Steady
AL ESRAA PHARMACEUTICALS (OPTIMA)
Registered &
Physical Address
Location : El Serag Mall,
Tower 3, Entrance No. 6, 5th Floor
Town : Cairo
Country : Egypt
Telephone : (20-2) 22742086
Facsimile : (20-2)
22742174
Email : marketing.department@esraapharma.com
Premises
Subject operates from a medium sized suite of offices that are rented
and located in the Central Business Area of Cairo.
Branch Offices
Location Description
Plot 17, Fourth Industrial Zone, Badr Industrial City Factory
premises
Cairo
Tel: (20-2) 28647886
Fax: (20-2) 28647885
Gamal Abdel Naser Street Office
premises
Alexandria
Tel: (20-3) 5562988
Ibn Al Farid Street Office
premises
Tanta
Tel: (20-111) 0444704
Taksem Al Hokokeyin Office
premises
Assiut
Name Position
Khalid Mohamed Mohamed El Gobaah Managing
Director
Walid El Dimilawy Director
Thamer Medhar Asim El Fakhany Director
Hassan Zaki Finance
Manager
Date of Establishment : 2011
Legal Form : Limited Liability
Company
Commercial Reg.
No. : 15076, Cairo
Tax Card No. : 212-899-066
Issued Capital : £E 3,000,000
Paid up Capital : £E 3,000,000
Name of
Shareholder (s)
Khalid Mohamed Mohamed El Gobaah
Walid El Dimilawy
Thamer Medhar Asim El Fakhany
Activities: Engaged in the manufacture of dental care products, skin care products
and pharmaceuticals.
Import Countries: Europe and the Far East.
Operating Trend: Steady
Subject has a workforce of 75 employees.
Financial highlights provided by local sources are given below:
Currency: Egyptian Pounds (£E)
Year Ending 31/12/13: Year Ending 31/12/14:
Total Sales £E
21,000,000 £E
22,370,000
Local sources consider subject’s financial condition to be Fair.
The above financial figures are based on estimations by our local
sources.
Banque Misr
151 Mohamed Farid Street
Cairo
Tel: (20-2) 33912711 / 33912106
Fax: (20-2) 33919779
No complaints regarding subject’s payments have been reported.
During the course of this investigation nothing detrimental was
uncovered regarding subject’s operating history or the manner in which payments
are fulfilled. As such the company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.65 |
|
|
1 |
Rs.99.14 |
|
Euro |
1 |
Rs.68.91 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.